Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK
Perceptive Discovery becomes the first US provider able to support At-211 studies, expanding access to specialized radiopharmaceutical development infrastructure through its collaboration with Atley Solutions BOSTON, Oct. 16, 2026 /PRNewswire/ -- Perceptive Discovery today announced the...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.